Cargando…

Effect of Hydralazine on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice

The rupture of an abdominal aortic aneurysm (AAA) causes about 200,000 deaths worldwide each year. However, there are currently no effective drug therapies to prevent AAA formation or, when present, to decrease progression and rupture, highlighting an urgent need for more research in this field. Inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yutang, Sargisson, Owen, Nguyen, Dinh Tam, Parker, Ketura, Pyke, Stephan J. R., Alramahi, Ahmed, Thihlum, Liam, Fang, Yan, Wallace, Morgan E., Berzins, Stuart P., Oqueli, Ernesto, Magliano, Dianna J., Golledge, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650676/ https://www.ncbi.nlm.nih.gov/pubmed/37958938 http://dx.doi.org/10.3390/ijms242115955

Ejemplares similares

Renal Denervation Promotes Atherosclerosis in Hypertensive Apolipoprotein E-Deficient Mice Infused with Angiotensin II
por: Wang, Yutang, et al.
Publicado: (2017)

Moxonidine Increases Uptake of Oxidised Low-Density Lipoprotein in Cultured Vascular Smooth Muscle Cells and Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Wang, Yutang, et al.
Publicado: (2023)

The penetration of methanol into bovine cardiac and hepatic tissues is faster than ethanol and formalin
por: Steicke, Michelle, et al.
Publicado: (2018)

Angiopoietin-2 attenuates angiotensin II-induced aortic aneurysm and atherosclerosis in apolipoprotein E-deficient mice
por: Yu, Hongyou, et al.
Publicado: (2016)

Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes
por: Wang, Yutang, et al.
Publicado: (2022)

Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm
por: Rush, Catherine, et al.
Publicado: (2009)

Hydralazine-Induced Vasculitis
por: Gandhi, Pulkit, et al.
Publicado: (2023)

Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
por: Zuckerman, Roman, et al.
Publicado: (2018)

Hydralazine-Induced Vasculitis With Gastrointestinal Pseudomelanosis
por: Novikov, Aleksey, et al.
Publicado: (2014)

Clinical Characteristics of Hydralazine-induced Lupus
por: Timlin, Homa, et al.
Publicado: (2019)

Hydralazine-Induced Isolated Lupus Nephritis
por: Khan, Naseer, et al.
Publicado: (2020)

Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
por: Strubchevska, Kateryna, et al.
Publicado: (2023)

Hydralazine target: From blood vessels to the epigenome
por: Arce, Claudia, et al.
Publicado: (2006)

Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
por: Bibby, M. C., et al.
Publicado: (1992)

Anti-neoplastic properties of hydralazine in prostate cancer
por: Graça, Inês, et al.
Publicado: (2014)

ANA-Negative Hydralazine-Induced Pericardial Effusion
por: Zeitjian, Vicken, et al.
Publicado: (2017)

Hydralazine-induced vasculitis presenting with ocular manifestations
por: Hawn, Vivian S., et al.
Publicado: (2022)

Impaired Acetylcholine-Induced Endothelium-Dependent Aortic Relaxation by Caveolin-1 in Angiotensin II-Infused Apolipoprotein-E (ApoE(−/−)) Knockout Mice
por: Seto, Sai Wang, et al.
Publicado: (2013)

Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E–deficient mice
por: Kunath, Anne, et al.
Publicado: (2021)

Response to Hydralazine-Valproate in a Patient with Mycosis Fungoides
por: Dueñas-Gonzalez, Alfonso, et al.
Publicado: (2010)

The mechanism of hydralazine-induced collagen biosynthesis in cultured fibroblasts
por: Karna, Ewa, et al.
Publicado: (2013)

Anti-TNF-α and hydralazine drug-induced lupus
por: Quaresma, Maria Victória, et al.
Publicado: (2015)

Comparison of Hydralazine and Labetalol to lower severe hypertension in pregnancy
por: Khan, Ayesha, et al.
Publicado: (2017)

Acute Low-Dose Hydralazine-Induced Lupus Pneumonitis
por: Holman, Sarah K., et al.
Publicado: (2017)

Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer
por: Lopes, Nair, et al.
Publicado: (2021)

Hydralazine augmented ultrasound hyperthermia for the treatment of hepatocellular carcinoma
por: Karmacharya, Mrigendra B., et al.
Publicado: (2021)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
por: Khosla, Atulya Aman, et al.
Publicado: (2023)

DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells
por: Candelaria, Myrna, et al.
Publicado: (2012)

Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
por: Stratford, I. J., et al.
Publicado: (1988)

Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
por: Siemann, D. W.
Publicado: (1990)

The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.
por: Quinn, P. K., et al.
Publicado: (1992)

Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
por: Al‐Mohammad, Abdallah
Publicado: (2019)

Hydralazine-Induced Lupus Syndrome Manifesting as Large Pericardial Effusion
por: Wilson, Nathaniel R, et al.
Publicado: (2020)

Hydralazine-Induced Lupus Presenting With Pancytopenia: A Case Report
por: Brar, Yudhveer, et al.
Publicado: (2022)

The Effects of Verapamil, Hydralazine, and Doxazosin on Renin, Aldosterone, and the Ratio Thereof
por: Veldhuizen, Gregory P., et al.
Publicado: (2021)

A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage
por: Xue, Angela, et al.
Publicado: (2023)

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
por: Echols, Melvin R, et al.
Publicado: (2006)

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndrome
por: Aeddula, Narothama Reddy, et al.
Publicado: (2018)

Hydralazine-Induced Dual Antineutrophil Cytoplasmic Antibody Positive Vasculitis and Nephritis
por: Padala, Sandeep A, et al.
Publicado: (2020)

Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines
por: Pacheco, Mariana Brütt, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6379gb92fna2kvuhcfljlr93o6